Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing hospital-centered safety monitoring of Yiqi Fumai Injection
ChiCTR-OPC-17012568Phase 4Completed
- Sponsor
- Evidence-Based Medicine Center of Tianjin University of Traditional Chinese Medicine
- Start
- Apr 2016
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of yiqi fumai, sponsored by Evidence-Based Medicine Center of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Safety. Started Apr 2016; status: completed.
02
Drugs
yiqi fumai
Beyond the preview
Go deeper on ChiCTR-OPC-17012568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17012568.